Effect of semaglutide 2.4 mg on alanine aminotransferase in adolescents with obesity: A post-hoc analysis of the STEP TEENS trial

Speaker

Dr. Ran Cheng, MD

Ran Cheng completed her endocrinology and metabolism training at Université de Montréal and is currently practicing at Hôpital Maisonneuve-Rosemont and Hôpital Santa-Cabrini in Montréal, Québec. Concurrently, she is pursuing a fellowship in Bariatric Medicine at the University of Ottawa. In addition to her clinical work and fellowship, she is actively engaged in academic pursuits and is currently enrolled in a master's degree program in biomedical sciences at Université de Montréal. Dr. Cheng's primary areas of professional interest revolve around obesity and diabetes management, along with their associated comorbidities. Her dedication to these fields reflects her commitment to advancing our understanding and treatment of these complex health conditions.